title: Binding of insulin-like growth factor II (IGF-II) by human cation-independent mannose 6-phosphate receptor/IGF-II receptor expressed in receptor-deficient mouse L cells.
abstract: Mouse L cells deficient in expression of the murine cation-independent mannose 6-phosphate receptor/insulin-like growth factor II receptor (CI-MPR/IGF-IIR) were stably transfected with a plasmid containing the cDNA for the human receptor. Transfected cells expressed high levels of the human receptor which functioned in the transport of lysosomal enzymes and was capable of binding 125I-IGF-II, both at the cell surface and intracellularly. Cell surface binding of 125I-IGF-II by the receptor could be inhibited by pretreatment of cells with antibodies to the receptor or by coincubation with the lysosomal enzyme, beta-glucuronidase. Expression of the receptor conferred on transfected cells the ability to internalize and degrade 125I-IGF-II. Cells transfected with the parental vector and those expressing the human CI-MRP/IGF-IIR were found to express an atypical binding site for IGF-II that was distinct from the CI-MPR/IGF-IIR and the type I IGF-receptor. The availability of two cell lines, one of which overexpresses the human CI-MPR/IGF-IIR and one deficient in expression of the murine receptor, may help in the analysis of the role of the receptor in mediating the biological effects of IGF-II. They should also be useful in examining the significance of binding of ligands, such as transforming growth factor-beta 1 precursor and proliferin to this receptor.
authors.affiliation: Edward A. Doisy Department of Biochemistry and Molecular Biology, St. Louis University School of Medicine, Missouri 63104.
authors.forename: C M
authors.initials: CM
authors.lastname: Nolan
authors.forename: J W
authors.initials: JW
authors.lastname: Kyle
authors.forename: H
authors.initials: H
authors.lastname: Watanabe
authors.forename: W S
authors.initials: WS
authors.lastname: Sly
mesh_terms: D000818:Animals; D004247:DNA / Q000235:genetics; D004705:Endocytosis; D005966:Glucuronidase / Q000494:pharmacology; D006801:Humans; D007335:Insulin-Like Growth Factor II / Q000378:metabolism*; D007739:L Cells / Q000378:metabolism; D008360:Mannosephosphates / Q000378:metabolism / Q000494:pharmacology; D051379:Mice; D017527:Receptor, IGF Type 2; D011956:Receptors, Cell Surface / Q000378:metabolism*; D017451:Receptors, Somatomedin; D011993:Recombinant Fusion Proteins / Q000378:metabolism
chemical_list: D008360:Mannosephosphates; D017527:Receptor, IGF Type 2; D011956:Receptors, Cell Surface; D017451:Receptors, Somatomedin; D011993:Recombinant Fusion Proteins; C027693:mannose-6-phosphate; D007335:Insulin-Like Growth Factor II; D004247:DNA; D005966:Glucuronidase